MAP2K7 and neoplasm: The RAS/RAF/MEK/ERK signaling pathway [mitogen-activated protein kinase (MAPK)] is associated with tumor cell proliferation and survival, particularly in cancers that harbor BRAF and/or RAS mutations[151].